GIM
BHC icon

Glenmede Investment Management’s Bausch Health BHC Stock Holding History

Glenmede Investment Management’s Portfolio BHC Stock Details BHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-2,500
Closed -$16.6K – 1484
2025
Q2 		$16.6K Buy
+2,500
New +$12.8K ﹤0.01% 1432

Other funds holding BHC

PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
GAM
Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
MP
MFN Partners Boston, Massachusetts $4.77B AUM 72.29% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Glenmede Investment Management's BHC Position: Q3 2025 in Review

Glenmede Investment Management sold out of Bausch Health (BHC) in Q3 2025, closing a stake of 2,500 shares — an estimated $16.6K sold.

Glenmede Investment Management first reported a position in BHC in Q2 2025 and held it in 1 quarter. The position peaked at $16.6K in Q2 2025. 219 funds tracked by Wall St. Rank hold BHC as of Q3 2025.

  • Glenmede Investment Management reported no remaining Bausch Health position as of Q3 2025 after selling out during the quarter.
  • Glenmede Investment Management sold 2,500 Bausch Health shares in Q3 2025, an estimated $16.6K.
  • Glenmede Investment Management first reported a position in Bausch Health in Q2 2025 and held it in 1 quarter.
  • Glenmede Investment Management's Bausch Health position peaked at $16.6K in Q2 2025.
  • 219 funds tracked by Wall St. Rank held Bausch Health as of Q3 2025.

Based on Glenmede Investment Management's 13F filing for Q3 2025, filed 13 Nov 2025.